Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I Receptor*

Transforming growth factor-β (TGF-β) signaling proceeds from the cell membrane to the nucleus through the cooperation of the type I and II serine/threonine kinase receptors and their downstream SMAD effectors. Although various regulatory proteins affecting TGF-β-mediated events have been described, relatively little is known about receptor interactions at the level of the plasma membrane. Caveolae are cholesterol-rich membrane microdomains that, along with their marker protein caveolin-1 (Cav-1), have been implicated in the compartmentalization and regulation of certain signaling events. Here, we demonstrate that specific components of the TGF-β cascade are associated with caveolin-1 in caveolae and that Cav-1 interacts with the Type I TGF-β receptor. Additionally, Cav-1 is able to suppress TGF-β-mediated phosphorylation of Smad-2 and subsequent downstream events. We localize the Type I TGF-β receptor interaction to the scaffolding domain of Cav-1 and show that it occurs in a physiologically relevant time frame, acting to rapidly dampen signaling initiated by the TGF-β receptor complex.

[1]  T. Michel,et al.  Agonist-modulated Targeting of the EDG-1 Receptor to Plasmalemmal Caveolae , 2000, The Journal of Biological Chemistry.

[2]  Wei Zhang,et al.  Caveolin-1 Inhibits Epidermal Growth Factor-stimulated Lamellipod Extension and Cell Migration in Metastatic Mammary Adenocarcinoma Cells (MTLn3) , 2000, The Journal of Biological Chemistry.

[3]  M. Lisanti,et al.  Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy. , 2000, Journal of cell science.

[4]  P. Narayan,et al.  Activated Cardiac Adenosine A1 Receptors Translocate Out of Caveolae* , 2000, The Journal of Biological Chemistry.

[5]  E. Bottinger,et al.  A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA , 2000, Genes & Development.

[6]  I. Stamenkovic,et al.  Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.

[7]  J. Engelman,et al.  Caveolins, Liquid-Ordered Domains, and Signal Transduction , 1999, Molecular and Cellular Biology.

[8]  K. Luo,et al.  Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein , 1999 .

[9]  C. Niehrs,et al.  Silencing of TGF-β signalling by the pseudoreceptor BAMBI , 1999, Nature.

[10]  M. Lisanti,et al.  Regulation of cAMP-mediated Signal Transduction via Interaction of Caveolins with the Catalytic Subunit of Protein Kinase A* , 1999, The Journal of Biological Chemistry.

[11]  Qiang Zhou,et al.  The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. , 1999, Genes & development.

[12]  M. Lisanti,et al.  A Role for the Caveolin Scaffolding Domain in Mediating the Membrane Attachment of Caveolin-1 , 1999, The Journal of Biological Chemistry.

[13]  M. Lisanti,et al.  Angiogenesis Activators and Inhibitors Differentially Regulate Caveolin-1 Expression and Caveolae Formation in Vascular Endothelial Cells , 1999, The Journal of Biological Chemistry.

[14]  J. Massagué,et al.  A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. , 1999, Genes & development.

[15]  C. Carman,et al.  Regulation of G Protein-coupled Receptor Kinases by Caveolin* , 1999, The Journal of Biological Chemistry.

[16]  H. Lodish,et al.  Transforming Growth Factor-β Induces Formation of a Dithiothreitol-resistant Type I/Type II Receptor Complex in Live Cells* , 1999, The Journal of Biological Chemistry.

[17]  J. Massagué,et al.  Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway , 1999, Nature.

[18]  M. Lisanti,et al.  Purification of caveolae-derived membrane microdomains containing lipid-anchored signaling molecules, such as GPI-anchored proteins, H-Ras, Src-family tyrosine kinases, eNOS, and G-protein alpha-, beta-, and gamma-subunits. , 1999, Methods in molecular biology.

[19]  Liliana Attisano,et al.  SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor , 1998, Cell.

[20]  B. Hogan,et al.  A mouse homologue of FAST-1 transduces TGFβ superfamily signals and is expressed during early embryogenesis , 1998, Mechanisms of Development.

[21]  J. Engelman,et al.  Targeted downregulation of caveolin‐1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade , 1998, The EMBO journal.

[22]  J. Engelman,et al.  Mutational analysis of caveolin‐induced vesicle formation , 1998, FEBS letters.

[23]  Richard J. Lee,et al.  Reciprocal Regulation of Neu Tyrosine Kinase Activity and Caveolin-1 Protein Expression in Vitro and in Vivo , 1998, The Journal of Biological Chemistry.

[24]  J. Engelman,et al.  Caveolin‐mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo , 1998, FEBS letters.

[25]  M. Lisanti,et al.  Caveolins, a Family of Scaffolding Proteins for Organizing “Preassembled Signaling Complexes” at the Plasma Membrane* , 1998, The Journal of Biological Chemistry.

[26]  H. Lodish,et al.  Oligomeric Structure of Type I and Type II Transforming Growth Factor β Receptors: Homodimers Form in the ER and Persist at the Plasma Membrane , 1998, The Journal of cell biology.

[27]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[28]  J. Kawabe,et al.  Caveolin Interaction with Protein Kinase C , 1997, The Journal of Biological Chemistry.

[29]  T. Pawson,et al.  Signaling through scaffold, anchoring, and adaptor proteins. , 1997, Science.

[30]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[31]  M. Lisanti,et al.  Interaction of a Receptor Tyrosine Kinase, EGF-R, with Caveolins , 1997, The Journal of Biological Chemistry.

[32]  E. V. van Donselaar,et al.  Cell-type and Tissue-specific Expression of Caveolin-2 , 1997, The Journal of Biological Chemistry.

[33]  C. Heldin,et al.  Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.

[34]  M. Kretzschmar,et al.  Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1 , 1997, Nature.

[35]  K. Miyazono,et al.  Smad6 inhibits signalling by the TGF-β superfamily , 1997, Nature.

[36]  R. Weinberg,et al.  Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Takeshi Imamura,et al.  TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4 , 1997 .

[38]  O. Féron,et al.  Dynamic Targeting of the Agonist-stimulated m2 Muscarinic Acetylcholine Receptor to Caveolae in Cardiac Myocytes* , 1997, The Journal of Biological Chemistry.

[39]  J. Massagué,et al.  Mechanism of TGFβ receptor inhibition by FKBP12 , 1997, The EMBO journal.

[40]  J. Wrana,et al.  The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.

[41]  M. Lisanti,et al.  Targeting of a G alpha subunit (Gi1 alpha) and c-Src tyrosine kinase to caveolae membranes: clarifying the role of N-myristoylation. , 1997, Cellular and molecular biology.

[42]  M. Lisanti,et al.  Molecular and cellular biology of caveolae paradoxes and plasticities. , 1997, Trends in cardiovascular medicine.

[43]  Tsuneya Ikezu,et al.  Identification of Peptide and Protein Ligands for the Caveolin-scaffolding Domain , 1997, The Journal of Biological Chemistry.

[44]  M. Lisanti,et al.  Mutational Analysis of the Properties of Caveolin-1 , 1997, The Journal of Biological Chemistry.

[45]  P. Hoodless,et al.  MADR2 Is a Substrate of the TGFβ Receptor and Its Phosphorylation Is Required for Nuclear Accumulation and Signaling , 1996, Cell.

[46]  M. Lisanti,et al.  Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. , 1996, The Journal of biological chemistry.

[47]  J. Massagué,et al.  Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.

[48]  H. Moses,et al.  Regulation of differentiation by TFG-β , 1996 .

[49]  R. Derynck,et al.  Receptor-associated Mad homologues synergize as effectors of the TGF-β response , 1996, Nature.

[50]  Allan Balmain,et al.  TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice , 1996, Cell.

[51]  P. Donahoe,et al.  The Immunophilin FKBP12 Functions as a Common Inhibitor of the TGFβ Family Type I Receptors , 1996, Cell.

[52]  A. Dehejia,et al.  Serine Phosphorylation, Chromosomal Localization, and Transforming Growth Factor-β Signal Transduction by Human bsp-1* , 1996, The Journal of Biological Chemistry.

[53]  G. Garcı́a-Cardeña,et al.  Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[54]  M. Lisanti,et al.  Co-purification and Direct Interaction of Ras with Caveolin, an Integral Membrane Protein of Caveolae Microdomains , 1996, The Journal of Biological Chemistry.

[55]  Richard G. W. Anderson,et al.  Acylation Targets Endothelial Nitric-oxide Synthase to Plasmalemmal Caveolae (*) , 1996, The Journal of Biological Chemistry.

[56]  H. Lodish,et al.  Molecular Cloning of Caveolin-3, a Novel Member of the Caveolin Gene Family Expressed Predominantly in Muscle (*) , 1996, The Journal of Biological Chemistry.

[57]  H. Lodish,et al.  Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M. Lisanti,et al.  Expression and Characterization of Recombinant Caveolin , 1996, The Journal of Biological Chemistry.

[59]  M. Masserini,et al.  A photo‐reactive derivative of ganglioside GM1 specifically cross‐links VIP21‐caveolin on the cell surface , 1995, FEBS letters.

[60]  F. Wieland,et al.  VIP21/caveolin is a cholesterol-binding protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[61]  C. Mineo,et al.  A detergent-free method for purifying caveolae membrane from tissue culture cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Lisanti,et al.  Oligomeric structure of caveolin: implications for caveolae membrane organization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[63]  H. Lodish,et al.  Caveolin Isoforms Differ in Their N-terminal Protein Sequence and Subcellular Distribution. IDENTIFICATION AND EPITOPE MAPPING OF AN ISOFORM-SPECIFIC MONOCLONAL ANTIBODY PROBE (*) , 1995, The Journal of Biological Chemistry.

[64]  M. Lisanti,et al.  Evidence for a Regulated Interaction between Heterotrimeric G Proteins and Caveolin , 1995, The Journal of Biological Chemistry.

[65]  A. Saltiel,et al.  Insulin stimulates the tyrosine phosphorylation of caveolin , 1995, The Journal of cell biology.

[66]  J. Massagué,et al.  GS domain mutations that constitutively activate T beta R‐I, the downstream signaling component in the TGF‐beta receptor complex. , 1995, The EMBO journal.

[67]  R. Weinberg,et al.  Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[68]  C. Albanese,et al.  c-Jun represses transcription of the human chorionic gonadotropin alpha and beta genes through distinct types of CREs. , 1994, The Journal of biological chemistry.

[69]  H. Lodish,et al.  Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles , 1994, The Journal of cell biology.

[70]  Jeffrey L. Wrana,et al.  Mechanism of activation of the TGF-β receptor , 1994, Nature.

[71]  M. Lisanti,et al.  Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. , 1994, Trends in cell biology.

[72]  R. F. Cook,et al.  Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease , 1994, The Journal of cell biology.

[73]  J. Massagué,et al.  Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin , 1994, Molecular and cellular biology.

[74]  K. Miyazono,et al.  Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor , 1993, Cell.

[75]  M. Lisanti,et al.  Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells , 1993, The Journal of cell biology.

[76]  B. Neel,et al.  Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. , 1993, Analytical biochemistry.

[77]  Jeffrey L. Wrana,et al.  TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.

[78]  D. Soppet,et al.  Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[79]  P. Dupree,et al.  VIP21, a 21-kD membrane protein is an integral component of trans-Golgi- network-derived transport vesicles , 1992, The Journal of cell biology.

[80]  R. Weinberg,et al.  Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase , 1992, Cell.

[81]  Richard G. W. Anderson,et al.  Caveolin, a protein component of caveolae membrane coats , 1992, Cell.

[82]  R. G. Anderson,et al.  Potocytosis: sequestration and transport of small molecules by caveolae. , 1992, Science.

[83]  K. Alitalo,et al.  Immediate early gene responses of NIH 3T3 fibroblasts and NMuMG epithelial cells to TGF beta-1. , 1991, Growth factors.

[84]  T. Hunter,et al.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.

[85]  J. Massagué,et al.  Type beta transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. , 1985, Proceedings of the National Academy of Sciences of the United States of America.